New Treatments for Hepatitis C
Dr. Dawn Sears
New Treatments and Important Current Health News
On this edition of, “Your Health Matters,” Dr. Dawn Sears, Hepatology Section Chief at Scott & White Healthcare, describes how two new FDA-approved drugs have doubled the cure rate for the liver-damaging Hepatitis C virus.
Dr. Dawn Sears is Hepatology Section Chief and GI Fellowship Program Director at Scott & White Healthcare's Temple, Texas clinic. She earned a B.S. from Texas Women's University and an M.D. from Texas A&M University College of Medicine, where she now serves as an Assistant Professor of Medicine. She trained in Internal Medicine and Gastroenterology at Scott & White, where she was appointed in 2004. Dr. Sears' patient care emphasis is autoimmune hepatitis, cirrhosis of the liver, colonoscopy, nonalcoholic steatohepatitis, pre & post liver transplant management, primary biliary cirrhosis, and viral hepatitis.
Channel Player (the latest segments)
Upcoming Live Shows
Login / Register